期刊文献+

茶树菇凝集素AAL、AAL-2检测小鼠CD8^+T淋巴细胞表面糖基化研究 被引量:2

Glycosylation of CD8^+ T Lymphocytes from C57BL/6 Mice Recognized by Agrocybe aegerita Lectins
原文传递
导出
摘要 本研究使用两种大型真菌茶树菇新型凝集素AAL(Agrocybe aegerita lectin)和AAL2(Agrocybe aegerita lectin 2),以检测小鼠CD8^+T淋巴细胞表面糖基化。用生物素标记的AAL和AAL2结合流式细胞仪,分别分析从C57BL/6小鼠脾脏和腹股沟淋巴结分离出来的CD8^+T淋巴细胞表面的糖基化水平,及其细胞因子表达水平。结果发现脾脏中AAL^+CD8^+,AAL2^+CD8^+T淋巴细胞所占的比例(%)分别为6.72±3.00和12.18±5.28,而腹股沟淋巴结的AAL^+CD8^+,AAL2^+CD8^+T淋巴细胞所占的比例(%)分别为12.18±5.28和10.15±3.46。细胞因子表达水平结果发现小鼠脾脏AAL2^+CD8^+T细胞表达perforin的细胞比例低于AAL2-CD8^+T细胞(p<0.05,有统计学意义),腹股沟淋巴结中AAL^+CD8^+T细胞表达perforin的细胞比例则高于AAL-CD8^+T细胞(p<0.05,有统计学意义)。该数据为研究小鼠脾脏和腹股沟淋巴结CD8^+T细胞表面糖基化提供了新的数据,也为两种新型凝集素AAL和AAL2的应用提供理论依据。 Two novel lectins, AAL(Agrocybe aegerita lectin) and AAL2(Agrocybe aegerita lectin 2), were employed to detect the glycosylation of CD8~+ T lymphocytes from C57BL/6 mouse spleen and inguinal lymph nodes. Biotinylated AAL and AAL2, combined with flow cytometry, were used to analyze the glycosylation of CD8~+ T lymphocytes and cytokine expression. The proportion(%) of AAL~+CD8~+ and AAL2~+CD8~+ T lymphocytes in spleen was found to be 6.72±3.00 and 12.18±5.28, respectively. The proportion(%) of AAL~+CD8~+ and AAL2~+CD8~+ T lymphocytes in lymph nodes was 12.18±5.28 and 10.15±3.46, respectively. Moreover, the frequency of perforin~+ cells in spleen AAL2~+CD8~+ T cells was lower than that in AAL2-CD8~+ T cells(p0.05), and the frequency of perforin~+ cells in lymph node AAL~+CD8~+ T cells was higher than that in AAL-CD8~+ T cells(p0.05). This study provides new data on the glycosylation of spleen and inguinal lymph node CD8~+ T cells and the application of two new lectins, AAL and AAL2.
出处 《现代食品科技》 EI CAS 北大核心 2017年第1期8-13,共6页 Modern Food Science and Technology
基金 国家自然科学基金项目(81102850) 广东省卫生厅基金项目(A2011434) 广东省教育厅育苗工程项目(LYM11070) 东莞市科技局项目(2011108102049) 湛江市科技攻关项目(2011C3109015) 广东医学院大学生创新实验项目(2013ZYDC004)
关键词 茶树菇凝集素 小鼠CD8+T淋巴细胞 糖基化 Agrocybe aegerita lectins CD8+T lymphocytes glycosylation
  • 相关文献

参考文献1

二级参考文献15

  • 1卞冬萍,杨振泉,方维明.灰树花胞外多糖特性研究进展[J].现代食品科技,2006,22(3):247-250. 被引量:4
  • 2BORCHERS Andrea T, KEEN Carl L, GERSHWIN M Eric. Mushrooms, tumors, and immunity: an update [J]. Experimental Biology and Medicine (Maywood), 2004, 229(5): 393-406.
  • 3ZAIDMAN Ben-Zion, YASSIN Majed, MAHAJNA Jamal, et al. Medicinal mushroom modulators of molecular targets as cancer therapeutics [J]. Applied Microbiology and Biotechnology, 2005, 67(4): 453-468.
  • 4LIANG Yi, CHEN Yijie, LIU Honghong, et al. The tumor rejection effect of protein components from medicinal fungus [J]. Biomedicine & Preventive Nutrition, 2011,1 (4): 245-254.
  • 5Liang Yi, CHEN -ijie, SUN Hui. Antiturnor activity of protein component fraction and small molecule component fraction from agrocybe aegerita through enhancement of different cytokine production [J]. Journal of Medicinal Food, 2014, DOI 10.1089/jmf.2013.2846.
  • 6ASSELIN Barbara L. The three asparaginases, comparative pharmacology and optimal use in childhood leukemia [J]. Advances in Experimental Medicine and Biology, 1999, 457: 621-629.
  • 7DRUCKER Daniel J, BUSE John B, TAYLOR Kristin, et al.Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study [J]. Lancet, 2008, 372(9645): 1240-1250.
  • 8LI Jin-hua, KING Ada V, STICKEL Sara L, et al. Whole tumor cell vaccine with irradiated s180 cells as adjuvant [J]. Vaccine, 2009, 27(4): 558-564.
  • 9MORTON Donald L, EILBER Friedman R, MALMGREN Richard A, et al. Immunological factors which influence response to immunotherapy in malignant melanoma [J]. Surgery, 1970, 68(1): 158-163.
  • 10CHEN Shi-an, TSAI Ming-huan, WU Fu-tien, et al. Induction of antitumor immunity with combination of her2/neu dna vaccine and interleukin 2 gene-modified tumor vaccine [J]. Clinical Cancer Research, 2000, 6(11): 4381-4388.

共引文献9

同被引文献51

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部